Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201105445 Principal Investigator: Ma, Cynthia
Title: A phase 1 trial of BKM 120, a novel oral selective phosphatidylinositol-3-kinase (PI3K) inhibitor, in combination with fulvestrant in postmenopausal women with estrogen receptor positive metastatic breast cancer
Phase: I Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to learn about the safety of BKM120 and fulvestrant when the two drugs are given together, to see what effects the combination of BKM120 and fulvestrant has on the body and on tumors, and to determine the highest safest dose of BKM120 that can be given in combination with a preapproved dose of fulvestrant.
 
More Information:
ClinicalTrials.gov #
Internal Protocol Documents (requires Siteman administrative database password)